Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Cartesian Therapeutics, Inc. | Chief Scientific Officer | Common Stock | 39.9K | $129K | $3.23 | Nov 20, 2024 | Direct |
Cartesian Therapeutics, Inc. | Chief Scientific Officer | Stock Option (Right to Buy) | 76.4K | $60.4K | $0.79 | Nov 20, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RNAC | Cartesian Therapeutics, Inc. | Nov 20, 2024 | 2 | $45.2K | 4 | Nov 21, 2024 | Chief Scientific Officer |
RNAC | Cartesian Therapeutics, Inc. | Nov 14, 2024 | 7 | -$707K | 4 | Nov 18, 2024 | Chief Scientific Officer |
RNAC | Cartesian Therapeutics, Inc. | Apr 8, 2024 | 2 | $0 | 4 | Apr 10, 2024 | Chief Scientific Officer |
RNAC | Cartesian Therapeutics, Inc. | Jan 2, 2024 | 2 | $0 | 4 | Jan 4, 2024 | Chief Scientific Officer |
SELB | Cartesian Therapeutics, Inc. | Nov 13, 2023 | 1 | $0 | 4 | Nov 15, 2023 | Chief Scientific Officer |
SELB | Cartesian Therapeutics, Inc. | Nov 13, 2023 | 0 | $0 | 3 | Nov 15, 2023 | Chief Scientific Officer |